Does NASDAQ use CureVac NV ordinary shares (CVAC) value to determine compliance?

NASDAQ does not use this value to determine compliance with the listing requirements. Discover real-time CureVac N.V. Ordinary Shares (CVAC) stock prices, quotes, historical data, news, and Insights for informed trading and investment decisions. Stay ahead with Nasdaq.

How much is CureVac (CVAC) stock now?

CureVac's stock was trading at $4.21 at the start of the year. Since then, CVAC stock has decreased by 22.1% and is now trading at $3.28. View the best growth stocks for 2024 here. When is CureVac's next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, April 23rd 2024.

Who owns CureVac stock?

CureVac's stock is owned by a variety of retail and institutional investors. Top institutional investors include Price T Rowe Associates Inc. MD (1.04%), Price T Rowe Associates Inc. MD (1.04%), Platinum Investment Management Ltd. (0.22%), Goldman Sachs Group Inc. (0.17%), Goldman Sachs Group Inc. (0.17%) and Norges Bank (0.14%).